menu
    • menu

    Company profile for SolasCure

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SolasCure is at the forefront of biologics innovation, utilizing biomimicry and evidence-based medicine. The company is actively engaged in the development of its initial investigational product, Aurase Wound Gel, a hydrogel containing an enzyme cloned from medical maggots. The goal is to accelerate the debridement process in chronic wounds. SolasCure's innovative debridement technology is designed to provide healthcare profes...
    SolasCure is at the forefront of biologics innovation, utilizing biomimicry and evidence-based medicine. The company is actively engaged in the development of its initial investigational product, Aurase Wound Gel, a hydrogel containing an enzyme cloned from medical maggots. The goal is to accelerate the debridement process in chronic wounds. SolasCure's innovative debridement technology is designed to provide healthcare professionals with advanced wound care products. By significantly improving the health and well-being of patients with chronic wounds, the company aims to make a positive impact in outpatient or home settings.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SolasCureunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Cambridge, Cambridgeshire, CB1 1BH
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://solascure.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/solascure/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Solascure Shows Fast Healing In Aurase Wound Gel Phase 2 Trial
    Solascure Shows Fast Healing In Aurase Wound Gel Phase 2 Trial

    24 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-24/solascure-completes-phase-ii-clinical-trial-demonstrating-accelerated-healing-with-aurase-wound-gel

    PHARMIWEB
    24 Feb 2026
    Share Share
    SolasCure Enrols First Patient in Phase II Aurase Trial
    SolasCure Enrols First Patient in Phase II Aurase Trial

    17 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250317814778/en/SolasCure-Enrols-First-Patient-in-a-Next-Phase-II-Clinical-Trial-to-Advance-Aurase-Wound-Gel

    BUSINESSWIRE
    17 Mar 2025
    Share Share
    SolasCure Partners with U.S. Army on Combat Wound Care Research
    SolasCure Partners with U.S. Army on Combat Wound Care Research

    06 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241106427616/en

    BUSINESSWIRE
    06 Nov 2024
    Share Share
    SolasCure Selected for Innovate UK Global Incubator Programme in Houston
    SolasCure Selected for Innovate UK Global Incubator Programme in Houston

    03 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240603567614/en

    BUSINESSWIRE
    03 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search